Invention Grant
US09248187B2 Oxadiazole inhibitors of leukotriene production for combination therapy
有权
用于组合治疗的白三烯生产的恶二唑抑制剂
- Patent Title: Oxadiazole inhibitors of leukotriene production for combination therapy
- Patent Title (中): 用于组合治疗的白三烯生产的恶二唑抑制剂
-
Application No.: US13755351Application Date: 2013-01-31
-
Publication No.: US09248187B2Publication Date: 2016-02-02
- Inventor: Lars Anders Bylock
- Applicant: Lars Anders Bylock
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Usha R. Patel
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K45/06 ; A61K31/497 ; A61K31/506 ; A61K31/5377 ; A61K31/541 ; A61K31/366 ; C07D413/14 ; C07D413/10 ; C07D417/14 ; C07D498/04 ; A61K31/4245
Abstract:
The present invention relates to combination therapy using compound of formula (I): or pharmaceutically acceptable salts thereof, wherein R1-R5 are as defined herein and an additional pharmaceutically active agent. The invention also relates to pharmaceutical compositions comprising these combinations, and methods of using these combinations in the treatment of various diseases and disorders.
Public/Granted literature
- US20130195879A1 OXADIAZOLE INHIBITORS OF LEUKOTRIENE PRODUCTION FOR COMBINATION THERAPY Public/Granted day:2013-08-01
Information query
